HIV Pathog Treat Conf. Capparelli E, Sullivan J, Mofenson L, Smith B, Graham B, Britto P, Becker M, Luzuriaga K. 8th Conf Retro and Opportun Infect. Oral, 1ml liquid contains 20 mg 1592U89. Oral, pediatric powder blend. Whether or not the plasma RNA copy number at 12 weeks is below the detection limit of the assay.
Patient requires treatment with medications that are disallowed while on the study.
The investigator determines that further participation would be detrimental to the patient's health or well being. The patient's legal guardian fails to comply with the study requirements so as to cause harm to self or seriously interfere with the validity of the study results. No longer recruiting 000802. Always watch for outdated information. This information is designed to support, not replace, the relationship that exists between you and your doctor.